CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model.
about
Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune responseDelivery of oligonucleotides with lipid nanoparticlesCRPV genomes with synonymous codon optimizations in the CRPV E7 gene show phenotypic differences in growth and altered immunity upon E7 vaccinationAdoptive transfer of human papillomavirus E7-specific CTL enhances tumor chemoresponse through the perforin/granzyme-mediated pathway.Mucosally delivered peptides prime strong immunity in HLA-A2.1 transgenic rabbits.Combined stimulation of IL-2 and 4-1BB receptors augments the antitumor activity of E7 DNA vaccines by increasing Ag-specific CTL responses.DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cellsUmbilical cord blood-derived dendritic cells loaded with BGC823 tumor antigens and DC-derived exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumor immunity in vitro and in vivoCXCL10 is critical for the generation of protective CD8 T cell response induced by antigen pulsed CpG-ODN activated dendritic cells.Targeted treatments for cervical cancer: a review.Human papillomavirus vaccines for the treatment of cervical cancer.CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer.Immunotherapy and targeted therapy for cervical cancer: an update.All-Atom MD Predicts Magnesium-Induced Hairpin in Chemically Perturbed RNA Analog of F10 Therapeutic.Suppression of antitumour protective cytotoxic T lymphocyte responses to a human papillomavirus 16 E7 DNA vaccine by coinjection of interleukin-12 complementary DNA: involvement of nitric oxide in immune suppression.In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer.Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model.Common vaccine antigens inhibit allergen-induced sensitization and airway hyperresponsiveness in a murine model.Therapeutic human papillomavirus vaccines: current clinical trials and future directions
P2860
Q26996330-326C377F-15F2-4221-9778-B8915541B67BQ27024646-8A604344-4034-49AF-93EB-4091CE7FA8A7Q28473368-08BED1C9-E07D-427B-840F-18F900F88655Q33713511-11038D96-6737-4CC1-97D1-31FF5941C44DQ33887085-BE593477-D618-43C1-93C5-2466802C70ECQ35082617-CB40243B-4D73-48EA-AA72-D01098B1569FQ35148074-96FC486C-9405-4668-8439-152BAE63651EQ35686234-4AF03507-B27D-4F11-BAD6-9532A708E28CQ36381011-6B4C3AAE-ADD8-476F-9A4E-89ACB5BE870FQ36384032-C7163674-ED98-402E-BC7A-92B92A42F54BQ36690278-F490D01F-5F86-4758-A5CA-81597F802FEBQ37568374-B2E729C3-0004-4EF3-9CAC-810A34C15C49Q38633525-B5DA031F-A565-47F4-BB03-6FE568C104E0Q38660825-A164260C-FAE7-4862-81B2-89271F7DDFA4Q39796159-AD09FDD1-6512-461C-86C0-A38F8629E8EEQ42279298-5417020C-384C-49CE-9804-2A1EFD5BD3CAQ43854654-E9599AD3-778C-465A-ADAA-D296E30A5F84Q52932193-F109F862-D8D2-4848-8AC4-514E00F4F870Q56937332-6687B660-B6B5-41B0-8CF2-32030DF8D8F0
P2860
CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
CpG-ODN-stimulated dendritic c ...... ssociated animal tumour model.
@en
CpG-ODN-stimulated dendritic c ...... ssociated animal tumour model.
@nl
type
label
CpG-ODN-stimulated dendritic c ...... ssociated animal tumour model.
@en
CpG-ODN-stimulated dendritic c ...... ssociated animal tumour model.
@nl
prefLabel
CpG-ODN-stimulated dendritic c ...... ssociated animal tumour model.
@en
CpG-ODN-stimulated dendritic c ...... ssociated animal tumour model.
@nl
P2093
P2860
P1433
P1476
CpG-ODN-stimulated dendritic c ...... ssociated animal tumour model.
@en
P2093
Chang-Hyun Kim
Eun Ha Won
Jae-Bok Park
Jeong-Im Sin
Tai-Gyu Kim
Woong-Shick Ahn
P2860
P304
P356
10.1111/J.1365-2567.2004.01851.X
P577
2004-05-01T00:00:00Z